Viewing Study NCT01492504


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2025-12-29 @ 11:25 PM
Study NCT ID: NCT01492504
Status: COMPLETED
Last Update Posted: 2019-11-27
First Post: 2011-11-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module